Dimaprit dihydrochloride
SIGMA/D7571 - ≥98% (NMR)
Synonym: Carbamimidothioic acid, 3-
CAS Number: 23256-33-9
Empirical Formula (Hill Notation): C6H15N3S · 2HCl
Molecular Weight: 234.19
MDL Number: MFCD00069260
Linear Formula: C6H15N3S · 2HCl
Product Type: Chemical
| assay | ≥98% (NMR) |
| color | white to off-white |
| form | powder |
| InChI | 1S/C6H15N3S.2ClH/c1-9(2)4 |
| InChI key | DFWCPLGXFMSUCW-UHFFFAOYSA |
| originator | Roche |
| Quality Level | 100  |
| SMILES string | Cl.Cl.CN(C)CCCSC(N)=N |
| solubility | H2O: ≥50 mg/mL |
| storage temp. | −20°C |
| Biochem/physiol Actions: | Selective histamine receptor H2 agonist. |
| Biochem/physiol Actions: | The histamine H2 receptor influences various cardiovascular responses, including vasodilation and cardiac rhythm, regulates gastric acid secretion, and also plays a role in the immune system by inhibiting antibody production, T cell proliferation and cytokine production. Histamine receptors are members of the GPCR family, and H2 mediates cell signaling via internalization and interaction with the GTPase dynamin. |
| Features and Benefits: | This compound is featured on the Histamine Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Features and Benefits: | This compound was developed by Roche . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol |  GHS07 |
| Signal word | Warning |
| Hazard statements | H315 - H319 - H335 |
| Precautionary statements | P261 - P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (NMR) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |